These include several prior validated targets affected in DCM patients with the RBM20 S635A mutation, such as TTN, CAMK2D, OBSCN, RYR2, IMMT, and TNNT2 (Fig. 4b–d, and Supplementary Fig. 5b)16. The gene discussed is RYR2; the disease is familial dilated cardiomyopathy.